Table 9.
Study or Subgroup | Celecoxib |
Diclofenac |
Weight | Peto OR, Fixed, 95% CI | ||
---|---|---|---|---|---|---|
Events | Total | Events | Total | |||
CAESAR 2009 [Dahlberg et al. 2009] | 1 | 458 | 5 | 458 | 25.2% | 0.26 [0.05, 1.30] |
CONDOR 2010 [Chan et al. 2010] | 3 | 2238 | 3 | 2246 | 25.3% | 1.00 [0.20,4.98] |
McKenna et al. [2001] | 0 | 201 | 2 | 199 | 8.4% | 0.13 [0.01, 2.14] |
SUCCESS-I [Singh et al. 2006] | 5 | 8800 | 6 | 4394 | 41.2% | 0.38 [0.11, 1.35] |
Total (95% CI) | 11597 | 7297 | 100.00% | 0.41 [0.18, 0.91] | ||
Total events | 9 | 16 |
Heterogeneity: chi squared = 2.14, degrees of freedom = 3 (p = 0.54); I2 = 0%. Test for overall effect: Z = 2.19 (p = 0.03).
CI, confidence interval; OR, odds ratio.